SALIX PHARMACEUTCLS (NASDAQ:SLXP)
26.91
0.06 (0.22%)
| SALIX PHARMACEUTCLS (NASDAQ:SLXP) Delayed : |
| Previous Close |
$26.97 |
|
52 Week High |
$29.91 |
|
| Open |
$26.89 |
|
52 Week Low |
$6.14 |
| Day High |
$27.20 |
|
P/E |
N/A |
| Day Low |
$26.54 |
|
EPS |
$-0.98 |
| Volume |
171,420 |
|
|
|
| More SLXP Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on SLXP
-
Feb 2, 2010 01:12 PM
Summer Street Initiates Coverage of Salix Pharmaceuticals (SLXP) with a Buy
-
Feb 1, 2010 10:38 AM
Notable Analyst Rating Changes 02/01: BIDU, ALV, G, ARG, ASH Upgraded; CPF, M, LZ, COGT, WCRX Downgraded
-
Feb 1, 2010 08:20 AM
Jefferies & Co Initiates Coverage on Salix Pharmaceuticals (SLXP) with a Buy
-
Jan 26, 2010 08:03 AM
Oppenheimer Upgrades Salix Pharmaceuticals (SLXP) to Outperform
-
Jan 7, 2010 09:45 AM
Salix (SLXP) February volatility at 58, April at 73 into FDA meeting
View All Reports
StreetInsider Reports on SLXP by Category
-
Jan 26, 2010 11:50 AM
Analyst Upgrades, Downgrades and Initiations: AMLN, CI, CTXS, HSY, KRA, TSCO, TXN ...
-
Jan 4, 2010 03:37 AM
Biotech’s 2009 Stealth Small Cap Rally
-
Oct 14, 2009 04:16 AM
FDA Calendar Extreme Trades: 85 Single Digit Stocks
-
Sep 29, 2009 11:06 AM
Salix: Approval of Rifaximin Would Help Drive Long-Term Growth
-
Sep 20, 2009 04:50 PM
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
View All Blogs
Comments on SLXP
No comments are currently available.